These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6954526)

  • 1. Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen.
    Barsh GS; David KE; Byers PH
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3838-42. PubMed ID: 6954526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular defect in an autosomal dominant form of osteogenesis imperfecta. Synthesis of type I procollagen containing cysteine in the triple-helical domain of pro-alpha 1(I) chains.
    de Vries WN; de Wet WJ
    J Biol Chem; 1986 Jul; 261(19):9056-64. PubMed ID: 3722186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.
    Willing MC; Cohn DH; Byers PH
    J Clin Invest; 1990 Jan; 85(1):282-90. PubMed ID: 2295701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.
    Pihlajaniemi T; McKeon J; Gay S; Gay R; de Wet WJ; Myers JC; Prockop DJ
    Biochem J; 1989 Jan; 257(2):439-45. PubMed ID: 2649075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
    Wenstrup RJ; Hunter AG; Byers PH
    Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the pro alpha 2(I) collagen gene in a patient with osteogenesis imperfecta.
    Dickson LA; Pihlajaniemi T; Deak S; Pope FM; Nicholls A; Prockop DJ; Myers JC
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4524-8. PubMed ID: 6087329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen.
    Deak SB; Nicholls A; Pope FM; Prockop DJ
    J Biol Chem; 1983 Dec; 258(24):15192-7. PubMed ID: 6418743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
    Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
    Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
    Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
    Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.
    Barsh GS; Byers PH
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5142-6. PubMed ID: 6946461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta.
    Wenstrup RJ; Willing MC; Starman BJ; Byers PH
    Am J Hum Genet; 1990 May; 46(5):975-82. PubMed ID: 2339695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta.
    Chessler SD; Byers PH
    J Biol Chem; 1993 Aug; 268(24):18226-33. PubMed ID: 8349698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta.
    Williams CJ; Prockop DJ
    J Biol Chem; 1983 May; 258(9):5915-21. PubMed ID: 6304100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta.
    de Wet WJ; Pihlajaniemi T; Myers J; Kelly TE; Prockop DJ
    J Biol Chem; 1983 Jun; 258(12):7721-8. PubMed ID: 6863261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta.
    Khillan JS; Olsen AS; Kontusaari S; Sokolov B; Prockop DJ
    J Biol Chem; 1991 Dec; 266(34):23373-9. PubMed ID: 1744131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta.
    Chessler SD; Wallis GA; Byers PH
    J Biol Chem; 1993 Aug; 268(24):18218-25. PubMed ID: 8349697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular heterogeneity in osteogenesis imperfecta type I.
    Willing MC; Pruchno CJ; Byers PH
    Am J Med Genet; 1993 Jan; 45(2):223-7. PubMed ID: 8456806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule.
    Lightfoot SJ; Holmes DF; Brass A; Grant ME; Byers PH; Kadler KE
    J Biol Chem; 1992 Dec; 267(35):25521-8. PubMed ID: 1460046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
    Constantinou CD; Nielsen KB; Prockop DJ
    J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic heterogeneity in osteogenesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1).
    Constantinou CD; Pack M; Young SB; Prockop DJ
    Am J Hum Genet; 1990 Oct; 47(4):670-9. PubMed ID: 2220807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.